BioElectronics Chairman of the Board Interview

  • December 1st, 2015
  • News
  • 0 Comments
  • bfichter

A New Audio Interview With Rick Staelin, Chairman of the Board for BioElectronics Corporation, is Now at SmallCapVoice.com AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now […]

BioElectronics’ ActiPatch® Pain Therapy Expands Into Costco Canada

  • November 19th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. November 19, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco’s online store, http://www.costco.ca/CatalogSearch?storeId=10302&catalogId=11201&langId=-24&refine=&keyword=actipatch. Chris Russell, President, Chris-Kelly, LLC, the Canadian distributor, stated, “This product placement in […]

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

  • November 9th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. November 9, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world’s largest international health and beauty […]

Chairman of BioElectronics Corporation Letter to Shareholders

  • October 22nd, 2015
  • News
  • 0 Comments
  • bfichter

The following is a letter from the Chairman of BioElectronics Corporation (OTC Pink: BIEL) to shareholders: October 22, 2015 Dear Biel Shareholders: This has been a busy last few months that has resulted in some very positive news for BIEL shareholders and I want to take a few minutes to put these events in perspective. […]

BioElectronics’ UK ActiPatch® Pain Therapy Market Expands Into 1,077 Lloyds Pharmacies and 60 Gordons Chemist

  • October 20th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. October 20, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received initial orders for its ActiPatch® Musculoskeletal Pain Relief products for 1,077 Lloyd’s pharmacies, the second largest chain in the UK, and Gordons Chemist. ActiPatch will be on promotion in […]

BioElectronics Applauds the FDA’s Reclassification of Nonthermal Shortwave Therapy Devices

  • October 14th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. October 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management endorsed the U.S. Food and Drug Administration’s final rule 890.5290 on nonthermal pulsed shortwave devices published today in the Federal Register. “I am pleased the agency has completed this step in streamlining the regulatory requirements […]

BioElectronics Supports Arthritis Campaign

  • September 21st, 2015
  • News
  • 0 Comments
  • bfichter

Osteoarthritis is the Most Common Cause of Disability FREDERICK, MD. September 21, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced that they are sponsoring the Arthritis Care Time for Tea campaign October 12-18, 2015. Time for Tea is organized by Arthritis Care, a registered UK charity […]

BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference

  • August 27th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD, USA, August 27, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that three abstracts featuring the use of ActiPatch®, its novel musculoskeletal pain therapy, will be presented at the 9th Congress of the European Pain Federation EFIC®, Vienna, Austria, 2-5th September 2015. The Company will […]

BioElectronics Reports Stronger Second Quarter Results

  • August 18th, 2015
  • News
  • 0 Comments
  • bfichter

Publishes Market Analysis of its Try & Tell Survey That Predicts Strong Ongoing Sales

FREDERICK, MD, USA, August 18, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today published on its second quarter financial results along with a market analysis of its long term follow up surveys of customers who are managing pain with ActiPatch Therapy.

BioElectronics Files FDA Premarket Notification for ActiPatch® Therapy

  • August 10th, 2015
  • News
  • 0 Comments
  • bfichter

The Most Innovative Treatment for Chronic Pain FREDERICK, MD. August 10, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management, announced the filing of a 510(k) Premarket Notification for ActiPatch® Therapy with the U.S. Food and Drug Administration. The market clearance request is for the adjunctive treatment of […]